Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression.

Talwar H, Bouhamdan M, Bauerfeld C, Talreja J, Aoidi R, Houde N, Charron J, Samavati L.

J Immunol. 2019 Mar 15;202(6):1815-1825. doi: 10.4049/jimmunol.1801477. Epub 2019 Feb 1.

PMID:
30710049
2.

Corrigendum to "MKP-1 negatively regulates LPS-mediated IL-1β production through p38 activation and HIF-1α expression". (Cell Signal. 34 (1-10) (2017) Epub 2017 Feb 24).

Talwar H, Bauerfeld C, Bouhamdan M, Farshi P, Liu Y, Samavati L.

Cell Signal. 2017 Oct;38:239. doi: 10.1016/j.cellsig.2017.06.003. Epub 2017 Jun 12. No abstract available.

PMID:
28619580
3.

MKP-1 negatively regulates LPS-mediated IL-1β production through p38 activation and HIF-1α expression.

Talwar H, Bauerfeld C, Bouhamdan M, Farshi P, Liu Y, Samavati L.

Cell Signal. 2017 Jun;34:1-10. doi: 10.1016/j.cellsig.2017.02.018. Epub 2017 Feb 24. Erratum in: Cell Signal. 2017 Oct;38:239.

4.

MEK1 dependent and independent ERK activation regulates IL-10 and IL-12 production in bone marrow derived macrophages.

Bouhamdan M, Bauerfeld C, Talreja J, Beuret L, Charron J, Samavati L.

Cell Signal. 2015 Oct;27(10):2068-76. doi: 10.1016/j.cellsig.2015.07.015. Epub 2015 Jul 21.

5.

Effects of gender on locomotor sensitivity to amphetamine, body weight, and fat mass in regulator of G protein signaling 9 (RGS9) knockout mice.

Walker PD, Jarosz PA, Bouhamdan M, MacKenzie RG.

Physiol Behav. 2015 Jan;138:305-12. doi: 10.1016/j.physbeh.2014.10.012. Epub 2014 Oct 22.

PMID:
25455864
6.

The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes.

Johnson MM, Michelhaugh SK, Bouhamdan M, Schmidt CJ, Bannon MJ.

Front Neurosci. 2011 Dec 20;5:135. doi: 10.3389/fnins.2011.00135. eCollection 2011.

7.
8.

Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity.

Michelhaugh SK, Vaitkevicius H, Wang J, Bouhamdan M, Krieg AR, Walker JL, Mendiratta V, Bannon MJ.

J Neurochem. 2005 Dec;95(5):1342-50.

9.

Preferential expression of an AAV-2 construct in NOS-positive interneurons following intrastriatal injection.

Sin M, Walker PD, Bouhamdan M, Quinn JP, Bannon MJ.

Brain Res Mol Brain Res. 2005 Nov 18;141(1):74-82. Epub 2005 Sep 8.

PMID:
16153741
11.

Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5.

Cordelier P, Kulkowsky JW, Ko C, Matskevitch AA, McKee HJ, Rossi JJ, Bouhamdan M, Pomerantz RJ, Kari G, Strayer DS.

Gene Ther. 2004 Nov;11(22):1627-37.

PMID:
15295615
12.

Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain.

Bouhamdan M, Michelhaugh SK, Calin-Jageman I, Ahern-Djamali S, Bannon MJ.

Biochim Biophys Acta. 2004 May 3;1691(2-3):141-50.

13.

Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN.

Mukhtar M, Harley S, Chen P, BouHamdan M, Patel C, Acheampong E, Pomerantz RJ.

Virology. 2002 May 25;297(1):78-88.

14.

Combination genetic therapy to inhibit HIV-1.

Strayer DS, Branco F, Landré J, BouHamdan M, Shaheen F, Pomerantz RJ.

Mol Ther. 2002 Jan;5(1):33-41.

15.

SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.

Jayan GC, Cordelier P, Patel C, BouHamdan M, Johnson RP, Lisziewicz J, Pomerantz RJ, Strayer DS.

Gene Ther. 2001 Jul;8(13):1033-42.

16.

Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.

BouHamdan M, Strayer DS, Wei D, Mukhtar M, Duan LX, Hoxie J, Pomerantz RJ.

Gene Ther. 2001 Mar;8(5):408-18.

17.

Pathogenesis of HIV-1 infection within bone marrow cells.

Kulkosky J, Bouhamdan M, Geist A, Nunnari G, Phinney DG, Pomerantz RJ.

Leuk Lymphoma. 2000 May;37(5-6):497-515. Review.

PMID:
11042510
18.

Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.

Strayer DS, Pomerantz RJ, Yu M, Rosenzweig M, BouHamdan M, Yurasov S, Johnson RP, Goldstein H.

Gene Ther. 2000 May;7(10):886-95.

20.
22.

The HIV-1 Vpr co-activator induces a conformational change in TFIIB.

Agostini I, Navarro JM, Bouhamdan M, Willetts K, Rey F, Spire B, Vigne R, Pomerantz R, Sire J.

FEBS Lett. 1999 May 7;450(3):235-9.

23.

Human immunodeficiency virus type 1 Vpr alters bone marrow cell function.

Kulkosky J, Laptev A, Shetty S, Srinivasan A, BouHamdan M, Prockop DJ, Pomerantz RJ.

Blood. 1999 Mar 15;93(6):1906-15.

24.

A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.

Kulkosky J, BouHamdan M, Geist A, Pomerantz RJ.

Virology. 1999 Mar 1;255(1):77-85.

25.

Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.

Ho WZ, Lai JP, Bouhamdan M, Duan L, Pomerantz RJ, Starr SE.

AIDS Res Hum Retroviruses. 1998 Nov 20;14(17):1573-80.

PMID:
9840290
26.

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells.

Rey F, BouHamdan M, Navarro JM, Agostini I, Willetts K, Bouyac M, Tamalet C, Spire B, Vigne R, Sire J.

J Gen Virol. 1998 May;79 ( Pt 5):1083-7.

PMID:
9603322
27.

Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins.

BouHamdan M, Xue Y, Baudat Y, Hu B, Sire J, Pomerantz RJ, Duan LX.

J Biol Chem. 1998 Apr 3;273(14):8009-16.

28.

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.

Agostini I, Navarro JM, Rey F, Bouhamdan M, Spire B, Vigne R, Sire J.

J Mol Biol. 1996 Sep 6;261(5):599-606.

PMID:
8800208
29.

Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Bouhamdan M, Benichou S, Rey F, Navarro JM, Agostini I, Spire B, Camonis J, Slupphaug G, Vigne R, Benarous R, Sire J.

J Virol. 1996 Feb;70(2):697-704.

30.

Zymosan-induced tyrosine phosphorylations in human monocytes. Role of protein kinase C.

Sanguedolce MV, Capo C, Bouhamdan M, Bongrand P, Huang CK, Mege JL.

J Immunol. 1993 Jul 1;151(1):405-14.

PMID:
7686943

Supplemental Content

Loading ...
Support Center